Le Lézard
Classified in: Health, Sports and recreation

American Academy of Sleep Medicine and Super Bowl Champion Aaron Taylor Team Up to Tackle Sleep Apnea


DARIEN, Ill., Nov. 14, 2018 /PRNewswire-PRWeb/ -- The American Academy of Sleep Medicine (AASM) and former NFL offensive lineman Aaron Taylor have partnered to launch two new public service announcements (PSAs) urging television viewers to "Defend Your Sleep" by talking to a doctor about obstructive sleep apnea ? a potentially life-threatening disease involving episodes of complete or partial airway obstruction during sleep. The PSAs, which will air now through the end of 2018, debut at a pivotal time, as research shows the number of U.S. adults who have sleep apnea is on the rise.

"Sleep apnea afflicts nearly 30 million American adults, and most of them remain untreated, increasing their risk of cardiovascular disease, hypertension, stroke and Type 2 diabetes," said AASM President Dr. Douglas B. Kirsch. "With Aaron's help, we hope to further educate the community about the warning signs of sleep apnea and demonstrate that many of the damaging effects of the disease can be stopped, and even reversed, through diagnosis and treatment by the sleep team at an accredited sleep center."

For Taylor, sleep apnea is personal. An avid snorer since he was in high school, he found himself with a lack of energy that began to affect his family life and performance on the field. However, it was not until two friends with sleep apnea died prematurely that he sought help from his doctor.

"At the end of the day, I wasn't going to let unhealthy sleep take away the opportunities I have in life to spend precious time with my wife and children," said Taylor. "My family encouraged me to undergo a sleep study, and it was one of the best decisions of my life because I started feeling like my old self again and getting more of what I wanted out of my life. I want to share my experience with others and hope these public service announcements further a much-needed conversation about sleep apnea."

In a 30-second PSA, Taylor speaks with studio host Adam Zucker and fellow football analysts Randy Cross and Brian Jones about the sleep apnea warning signs that he experienced. Taylor also urges viewers to get help for sleep apnea in a 15-second PSA.

According to the AASM, typical risk factors and symptoms of sleep apnea include:

For more information, visit DefendSleep.com. To request a copy of the PSAs or an interview with Taylor about his personal experience with sleep apnea, please email mkasik(at)lcwa(dot)com.

About the American Academy of Sleep Medicine
Established in 1975, the American Academy of Sleep Medicine (AASM) improves sleep health and promotes high quality, patient-centered care through advocacy, education, strategic research, and practice standards. The AASM has a combined membership of 10,000 accredited member sleep centers and individual members, including physicians, scientists and other health care professionals.

 

SOURCE American Academy of Sleep Medicine


These press releases may also interest you

at 00:05
ImmunityBio, Inc. , an immunotherapy company, today announced positive overall survival results in the QUILT 3.055 study of 2nd- and 3rd-line NSCLC patients who progressed after checkpoint inhibitor therapy (pembrolizumab, nivolumab, or atezolizumab)...

at 00:05
The Insurance Institute for Highway Safety is updating its vehicle-to-vehicle front crash prevention test to address crashes that occur at higher speeds and those in which the struck vehicle is a motorcycle or large truck. Only one of the first 10...

at 00:00
Nutriessential.com recently announced its expansion into Oceania, Asia, and the Gulf. The company has been providing science-backed GMP-certified supplements in the US, Europe and Canada since 2005 and decided to expand owing to rising global demands...

24 avr 2024
Summit Clinical Research LLC ("Summit") is deeply saddened by the death of Co-Founder and Chairman Dr. Stephen Harrison. Summit mourns Dr. Harrison and extends its heartfelt condolences to his family and loved ones.   During an illustrious 30-year...

24 avr 2024
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...

24 avr 2024
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...



News published on and distributed by: